U.S. panel rejects Philip Morris claim iQOS device cuts disease risk

WASHINGTON (Reuters) - Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.

U.S. panel rejects Philip Morris claim iQOS device cuts disease risk
Read More


Bagikan Berita Ini